Oncology/Hematology Market Research Reports & Industry Analysis

Cancer is the second-leading cause of death in the United States, and the world market for cancer therapeutics is growing at a brisk double-digit pace, with revenues surpassing $40 billion this year. MarketResearch.com presents the information you need to understand the Oncology & Hematology Industries, with oncology and hematology reports that provide insight into market trends, analyses, opportunities, projections, sales, and marketing strategies. Our hematology and oncology reports feature specifics on market share, segmentation, size, and growth in the US and global markets.
...Show More ...Show Less


Oncology/Hematology Industry Research & Market Reports

  • The 2025-2030 World Outlook for Breast Cancer Imaging Devices

    ... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More

  • The 2025-2030 World Outlook for Ovarian Cancer Diagnostics

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Ovarian Cancer Drugs

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Blood Cancer Therapeutics

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Generic Oncology Drugs

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Blockbuster Oncology Brands

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Cancer Screenings

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Cancer Supportive Care

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Cancer Stem Cells

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Hodgkins Lymphoma Drugs

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Blood-Product Hematology Drugs

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Endocrine Pancreatic Cancer Drugs

    ... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More

  • The 2025-2030 World Outlook for Breast Cancer Diagnostics and Drug Technologies

    ... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More

  • The 2025-2030 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care

    ... year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of ... Read More

  • The 2025-2030 World Outlook for Hematology and Oncology Products

    ... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More

  • The 2025-2030 World Outlook for Cancer Testing-Screening

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Cancer Therapeutics

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Radiation Oncology

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Pancreatic Cancer Drugs

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

  • The 2025-2030 World Outlook for Immunotherapy Drugs

    ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More

  • The 2025-2030 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb)

    ... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More

  • The 2025-2030 World Outlook for Immuno-Oncology

    ... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More

  • The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs

    ... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More

  • The 2025-2030 World Outlook for Non-Small Cell Lung Cancers

    ... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More

  • The 2025-2030 World Outlook for Non-Melanoma Skin Cancers

    ... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings